Venture Capital

With a deficit of 86,000 doctors looming, technology like AI is being touted as a key solution to save primary care from administrative overload.

Gwyneth Paltrow's chef-driven ghost kitchen arrives in Manhattan, testing its high-tech, delivery-first model against the city's toughest food critics.

As EBONY marks its 80th anniversary, the iconic Power 100 list returns with public nominations, aiming to redefine influence and celebrate a new generation.

At AACR 2026, CREATE Medicines debuts its RetroT platform, an all-RNA system for stable gene delivery that avoids viral vectors and reshapes cell therapy.

Dallas's EarthX E-Capital Summit shifts focus to market-based solutions, aiming to bridge divides and channel billions into scalable climate tech.

Tarte Cosmetics and wellness brand FINNSUL sold out in days using dorm drops and BookTok, not ads. Here’s the new playbook for winning modern consumers.

A new report reveals the Nordic life science sector isn't lacking female talent; it's failing to convert it into leadership, threatening innovation.

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

As the playoffs begin, Jaylen Brown and the Holidays are expanding their creator accelerator, a model now inspiring federal policy to empower entrepreneurs.

Tacotarian and KLIMON team up at Las Vegas's Sick New World festival, proving that plant-based dining is the new, indulgent headliner for festival fare.

Rep. Ben Cline's Legislator of the Year award from the NSSF highlights major legislative wins, including the removal of a key NFA tax for suppressors.

The premium tequila brand commits to tackling homelessness, hunger, and veteran support, but will its bold social pledge deliver measurable impact?

A Beijing seminar showcases China's tech-driven sustainability and poverty reduction models, drawing keen interest from developing nations.

With new CEO Sharath Ravikumar and fresh investment, legacy café brand Cuppa is betting on a franchise model to conquer India's booming coffee market.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

A European consortium has won €1.3M to develop a precision therapy for chronic urticaria, offering new hope for millions with uncontrolled symptoms.

With $36M secured, Orthogon Therapeutics is advancing a first-in-class oral drug for BK virus, offering a new lifeline for transplant patients.

Making its international debut at Hannover Messe, Chinese innovator Aiverest unveils advanced exoskeletons for industry, rescue, and personal mobility.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

Kansas City's new voting machines led to two-minute voting and higher confidence, but the rollout highlights broader debates on election tech costs and security.